NovoCure Limited

NASDAQ:NVCR

16.9 (USD) • At close October 17, 2024
Bedrijfsnaam NovoCure Limited
Symbool NVCR
Munteenheid USD
Prijs 16.9
Beurswaarde 1,828,867,300
Dividendpercentage 0%
52-weken bereik 10.87 - 24.735
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Asaf Danziger
Website https://www.novocure.com

An error occurred while fetching data.

Over NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune

Vergelijkbare Aandelen

Masimo Corporation logo

Masimo Corporation

MASI

142.95 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

118.46 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

24.39 USD

Repligen Corporation logo

Repligen Corporation

RGEN

142.14 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

69.23 USD

Bruker Corporation logo

Bruker Corporation

BRKR

60.49 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

8.11 USD

Acadia Healthcare Company, Inc. logo

Acadia Healthcare Company, Inc.

ACHC

59.32 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)